Applications
Enabling Scientific Breakthroughs
Get gene expression data faster and use less samples to critically evaluate disease progression and treatment. Our proprietary technology provides targeted gene expression profiling data to better understand various applications including infectious disease, oncology and immunology.
- COVID-19 and other infectious diseases
- miRNA
- Oncology Research
- Immune Response
- Lymphoma
COVID-19
Decode the Complexities of the Immune System’s Response to COVID-19 and Other Infectious Diseases
Learn how the HTG EdgeSeq Immune Response Panel rapidly evaluates changes in human gene expression in response to pathogenic infection.- Explore the immune response to COVID-19 infection and the disparity in patient response
- Identify biomarkers involved in the innate immune response over the course of infection
- Accelerate drug discovery by identifying and validating molecular pathways affected by infectious diseases
miRNA
Comprehensive Solution to Measure miRNA Expression Changes in Response to Disease
Measure the expression level of 2,083 human miRNAs and unlock the potential of miRNA expression with the HTG EdgeSeq miRNA Whole Transcriptome Panel.- Quickly gain valuable insight into disease progression using miRNA biomarker expression
- Measure the expression levels of miRNAs from human and other species due to miRNA sequence homology
- Increase sensitivity by retaining small and fragmented miRNAs with our proprietary extraction-free sample preparation chemistry
Oncology Research
Enhancing Research Collaborations
The HTG EdgeSeq platform contains expertly curated oncology gene panels to help advance your research programs and take advantage of the HTG EdgeSeq Reveal signatures.
- Quickly identify biomarkers using differential gene expression analysis
- Compare retrospectively collected cohorts to identify key genes and pathway differences
- Discovery to diagnostics on a single platform
- Stratify cohort samples using differential gene expression
- Identify the relative abundance of immune cell types, identify hot/cold tumors and determine the Cell of Origin for DLBCL lymphomas
Immune Response
Innovative Solutions to Measure Gene Expression Associated with the Body’s Immune Response
The HTG EdgeSeq Immune Response Panel was designed to measure the gene expression profile of mRNAs associated with the body’s immune response and changes to gene expression throughout disease progression.
- Study disease progression with the innate immune response
- Map new biomarkers using expression of autoimmune disease
- Innate response to pathogen infection and pathway identification
- Characterize COVID-19 disease progression and severity through gene expression
Lymphoma
Identify Distinct Signature of Lymphoma Subgroups
Learn how HTG EdgeSeq Reveal signatures can help you determine the Cell Of Origin (COO) for lymphoma subtypes.
- Utilize differential gene expression to determine lymphoma subtypes or develop new biomarkers
- Elucidate genes involved in transcriptional response to disease state or drug therapy
- Determine Cell of Origin subtype using HTG EdgeSeq Reveal DLBCL COO Signature
